Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial

Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.0%
    Check dated 2025-01-20T00:50:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T19:14:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T23:03:28.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.
    Difference
    2%
    Check dated 2024-12-07T17:13:46.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Several key resources related to genetics and health, including MedlinePlus and DailyMed links, have been removed, which may impact access to important medical information.
    Difference
    3%
    Check dated 2024-11-23T05:12:20.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new links related to genetics, hypertension, and diabetes, as well as resources from HHS, NIH, and NLM, while removing the previous version 2.12.1.
    Difference
    3%
    Check dated 2024-11-08T18:46:49.000Z thumbnail image

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.